Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Glatirameeracetaat: ook risico op anafylactische reacties lang na start behandeling
sep 2024 | Multipele Sclerose